FEMARA Side Effects

6815237-1 | Arthralgia, Hyperhidrosis, Major Depression
on Jul 01, 2010 Female patient from UNITED STATES , 59 years of age, weighting 180.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, hyperhidrosis, major depression. Femara dosage: 1 X A Day.

6810402-1 | Dialysis
Patient was taking Femara (View Usage). Patient had the following side effects: dialysis (What is dialysis?) on Jun 16, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 5 Mg/day. Patient was hospitalized.

6810371-4 | Hypocalcaemia, Hypokalaemia
Adverse event was reported on Jun 15, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?), hypercalcaemia and. Location: JAPAN , 60 years of age, After Femara was administered, patient had the following side effects: hypocalcaemia, hypokalaemia. During the same period patient was treated with ZOMETA (Unk) (View Zometa Review and Zometa Label ). Patient was hospitalized.

6810318-0 | Arthralgia, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Infection, Malaise, Pyrexia, Rash, Somnolence, White Blood Cell Count Decreased
on Jun 17, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, infection (What is infection?), malaise, pyrexia, rash (What is rash?), somnolence, white blood cell count decreased. Femara dosage: .


6795043-7 | Visual Acuity Reduced
on Jun 15, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient had the following side effects: visual acuity reduced. Femara dosage: 1 Df, Qd.

6790052-6 | Brain Neoplasm, Malignant Neoplasm Progression
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: brain neoplasm, malignant neoplasm progression on Jun 22, 2010 from INDIA Additional patient health information: Female patient , 44 years of age, . Femara dosage: 1 Df, Qd.

6781353-6 | Metastases To Liver, Metastases To Lung
Adverse event was reported on Jun 16, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) . Location: INDIA , 72 years of age, Patient experienced the following unwanted or unexpected effects: metastases to liver, metastases to lung.

6779416-4 |
on Jun 16, 2010 Female patient from INDIA , 90 years of age, was treated with Femara (View Usage). . Femara dosage: 1 Df, Qd.

6779387-0 | Lung Infection
on Jun 14, 2010 Female patient from INDIA , 75 years of age, was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: lung infection. Femara dosage: 2.5 Mg, Unk.

6771614-9 | Insomnia, Myalgia, Urge Incontinence
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia, myalgia, urge incontinence on Jun 04, 2010 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: One Tablet Every Other Day.

6771580-6 | Erythema, Lip Swelling
Adverse event was reported on Jun 03, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: erythema, lip swelling.

6771283-8 |
on Jun 11, 2010 Female patient from INDIA , 49 years of age, was treated with Femara (View Usage). . Femara dosage: 2.5 Mg/day.

6767797-7 | Hypokalaemia, Myopathy
on Jun 03, 2010 Female patient from JAPAN , 58 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, myopathy. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), MARZULENE S (View Marzulene S Review and Marzulene S Label ), GASTER D (View Gaster D Review and Gaster D Label ), VITANEURIN (View Vitaneurin Review and Vitaneurin Label ), TAKA DIASTASE (View Taka-diastase Review and Taka-diastase Label ). Patient was hospitalized.

6765562-8 | Arthralgia, Ascites, Breast Prosthesis Implantation, Cataract, Fluid Retention, Medical Device Complication, Moaning, Oedema Peripheral, Weight Increased
Patient was taking Femara (View Usage). Patient had the following side effects: arthralgia, ascites, breast prosthesis implantation, cataract (What is cataract?), fluid retention, medical device complication, moaning, oedema peripheral, weight increased on May 28, 2010 from AUSTRIA Additional patient health information: Female patient , 66 years of age, was diagnosed with breast cancer (What is breast cancer?), dehydration and. Femara dosage: Unk. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ZOMETA (Unk) (View Zometa Review and Zometa Label ).

6756219-8 | Malignant Neoplasm Progression, Respiratory Arrest
Adverse event was reported on May 28, 2010 by a Female patient taking Femara (View Usage) (Dosage: 1 (tablet) 2.5 Mg, Qd) was diagnosed with metastases to lung and. Location: MEXICO , 94 years of age, After Femara was administered, patient had the following side effects: malignant neoplasm progression, respiratory arrest.

6756178-8 | Knee Arthroplasty
on May 24, 2010 Female patient from UNITED STATES , weighting 202.8 lb, was diagnosed with breast cancer metastatic, hypertension and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: knee arthroplasty. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with ATENOLOL (25 Mg, Qd) (View Atenolol Review and Atenolol Label ), SYNTHROID (75 Mg, Unk) (View Synthroid Review and Synthroid Label ), MEVACOR (View Mevacor Review and Mevacor Label ). Patient was hospitalized.

6756170-3 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Chest Pain, Coeliac Artery Stenosis, Cold Sweat, Diverticulum Gastric, Dyspnoea, Lipase Increased
on May 20, 2010 Female patient from UNITED STATES , weighting 173.9 lb, was diagnosed with breast cancer (What is breast cancer?), hypothyroidism and was treated with Femara (View Usage). Patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, chest pain (What is chest pain?), coeliac artery stenosis, cold sweat, diverticulum gastric, dyspnoea, lipase increased. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with SYNTHROID (88 Mg, Qd) (View Synthroid Review and Synthroid Label ), ALPHAGAN (1 Drp, Tid) (View Alphagan Review and Alphagan Label ), COSOPT (1 Drp, Bid) (View Cosopt Review and Cosopt Label ), NORVASC (Unk) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6755947-8 | Abdominal Discomfort, Abdominal Pain, Conversion Disorder, Depression, Hyperventilation, Somnolence, Stress
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: abdominal discomfort, abdominal pain (What is abdominal pain?), conversion disorder, depression (What is depression?), hyperventilation, somnolence, stress (What is stress?) on May 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 83 years of age, weighting 108.0 lb, was diagnosed with breast cancer (What is breast cancer?), neuralgia, angina pectoris, transient ischaemic attack, hypertension, cardiac failure, infected skin ulcer, hypothyroidism and. Femara dosage: 2.5 Mg, Unk. During the same period patient was treated with AMITRIPTYLINE (25 Mg, Unk) (View Amitriptyline Review and Amitriptyline Label ), ANGEZE (30 Mg, Unk) (View Angeze Review and Angeze Label ), ACETYLSALICYLIC ACID (75 Mg, Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ERYTHROMYCIN (500 Mg, Qid) (View Erythromycin Review and Erythromycin Label ), LEVOTHYROXINE SODIUM (100 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NICORANDIL (20 Mg, Unk) (View Nicorandil Review and Nicorandil Label ).

6748696-3 | Arthralgia, Blood Calcium Increased, Blood Potassium Decreased, Hypercalcaemia, Hypocalcaemia, Nausea
Adverse event was reported on May 17, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?), hypercalcaemia and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, blood calcium increased, blood potassium decreased, hypercalcaemia, hypocalcaemia, nausea (What is nausea?). During the same period patient was treated with ZOMETA (Unk) (View Zometa Review and Zometa Label ). Patient was hospitalized.

6743128-3 | Lip Swelling
on May 13, 2010 Female patient from UNITED STATES , 66 years of age, was treated with Femara (View Usage). Patient had the following side effects: lip swelling. Femara dosage: 2.5 Mg, Qd.

6743125-8 | Foreign Body Sensation In Eyes, Retinal Haemorrhage, Retinal Vein Occlusion, Vision Blurred, Visual Acuity Reduced
on May 13, 2010 Female patient from JAPAN , weighting 136.7 lb, was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: foreign body sensation in eyes, retinal haemorrhage, retinal vein occlusion, vision blurred, visual acuity reduced. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with FLUVASTATIN (30 Mg) (View Fluvastatin Review and Fluvastatin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6738470-6 | Chest Pain, Dyspnoea, Intestinal Stenosis, Muscle Spasms, Pulmonary Embolism, Tachycardia, Thrombosis
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, intestinal stenosis, muscle spasms, pulmonary embolism (What is pulmonary embolism?), tachycardia, thrombosis on May 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 173.9 lb, was diagnosed with breast cancer (What is breast cancer?), hypothyroidism and. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with SYNTHROID (88 Mg, Qd) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6735426-4 | Breast Cancer Metastatic, Chronic Obstructive Pulmonary Disease, Dyspnoea, Respiratory Failure
Adverse event was reported on May 17, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 126.1 lb, Patient had the following side effects: breast cancer metastatic, chronic obstructive pulmonary disease, dyspnoea, respiratory failure. Patient was hospitalized.

6731966-2 | Dementia Alzheimer's Type
on May 04, 2010 Female patient from MEXICO , 69 years of age, was diagnosed with neoplasm malignant, dementia alzheimer's type, nervousness and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: dementia alzheimer's type. Femara dosage: 1 Tablet (2.5) Daily; Unk. During the same period patient was treated with ERANZ (1 Tablet Daily; Unk) (View Eranz Review and Eranz Label ), RISPERDAL (1 Tablet; Unk) (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6731279-9 | Arthralgia, Joint Stiffness, Oedema Peripheral, Pain In Extremity
on May 17, 2010 Female patient from UNITED STATES , 64 years of age, weighting 130.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, joint stiffness, oedema peripheral, pain in extremity. Femara dosage: 2.4 Mg 1 Day Oral.

6725817-X | Bone Pain, Osteochondrosis
Patient was taking Femara (View Usage). Patient had the following side effects: bone pain, osteochondrosis on May 03, 2010 from GERMANY Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 2.5 Mg, Daily. During the same period patient was treated with CALCIUM WITH VITAMIN D (Unk) (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ).

6724378-9 | Blood Cortisol Increased, Depression, Insomnia, Weight Decreased
Adverse event was reported on May 03, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: SLOVENIA , 55 years of age, After Femara was administered, patient had the following side effects: blood cortisol increased, depression (What is depression?), insomnia, weight decreased. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), TERTENSIF (View Tertensif Review and Tertensif Label ), EZETROL (View Ezetrol Review and Ezetrol Label ).

6721883-6 | Clear Cell Endometrial Carcinoma, Endometrial Cancer Metastatic, Metastases To Peritoneum, Metrorrhagia
on Apr 30, 2010 Female patient from FRANCE , weighting 123.5 lb, was diagnosed with breast cancer (What is breast cancer?), diabetes mellitus, osteopenia and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: clear cell endometrial carcinoma, endometrial cancer metastatic, metastases to peritoneum, metrorrhagia. Femara dosage: 2.5 Mg, Unk. During the same period patient was treated with METFORMIN HCL (850 Mg, Tid) (View Metformin Hcl Review and Metformin Hcl Label ), FIXICAL (Unk) (View Fixical Review and Fixical Label ). Patient was hospitalized.

6720308-4 | Dementia Alzheimer's Type
on May 04, 2010 Female patient from MEXICO , 69 years of age, was diagnosed with neoplasm malignant, dementia alzheimer's type, nervousness and was treated with Femara (View Usage). Patient had the following side effects: dementia alzheimer's type. Femara dosage: 1 Tablet (2.5) Daily; Unk. During the same period patient was treated with ERANZ (1 Tablet Daily; Unk) (View Eranz Review and Eranz Label ), RISPERDAL (1 Tablet; Unk) (View Risperdal Review and Risperdal Label ).

6720302-3 | Arthropathy, Fall, Knee Operation, Osteopenia
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: arthropathy, fall (What is fall?), knee operation, osteopenia on Apr 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 193.0 lb, . Femara dosage: 2.5 Daily.

6717194-5 | Groin Pain, Muscle Spasms, Pollakiuria
Adverse event was reported on Apr 28, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with ovarian cancer, hypertension, arthralgia and. Location: UNITED STATES , weighting 199.5 lb, Patient experienced the following unwanted or unexpected effects: groin pain, muscle spasms, pollakiuria. During the same period patient was treated with METOPROLOL (25 Mg, Qd) (View Metoprolol Review and Metoprolol Label ), ALEVE (CAPLET) (220 Mg, Unk) (View Aleve (caplet) Review and Aleve (caplet) Label ).

6716957-X | Idiopathic Thrombocytopenic Purpura
on May 06, 2010 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura. Femara dosage: . Patient was hospitalized.

6706415-0 | Blood Glucose Increased
on Apr 23, 2010 Female patient from FRANCE , 84 years of age, was diagnosed with breast mass and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: blood glucose increased. Femara dosage: 2.5 Mg, Qd For 3 Days. During the same period patient was treated with CARDENSIEL (View Cardensiel Review and Cardensiel Label ), NOVONORM (1 Mg) (View Novonorm Review and Novonorm Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ), EZATOR (View Ezator Review and Ezator Label ).

6701753-X | Diabetes Mellitus Inadequate Control, Weight Decreased
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, weight decreased on Apr 21, 2010 from JAPAN Additional patient health information: Female patient , 86 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: .

6701740-1 | Pulmonary Mycosis
Adverse event was reported on Apr 20, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 70 years of age, Patient had the following side effects: pulmonary mycosis. Patient was hospitalized.

6701738-3 | Dyspnoea, Heart Rate Irregular, Palpitations, Supraventricular Extrasystoles
on Apr 20, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: dyspnoea, heart rate irregular, palpitations, supraventricular extrasystoles. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with BONIVA (View Boniva Review and Boniva Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), DIAZIDE (View Diazide Review and Diazide Label ).

6695199-0 | Arthralgia, Balance Disorder, Dizziness, Headache, Hypercholesterolaemia, Musculoskeletal Pain, Myalgia, Oophorectomy
on Mar 22, 2010 Female patient from GERMANY , 55 years of age, was diagnosed with breast cancer (What is breast cancer?), prophylaxis, pain (What is pain?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, balance disorder, dizziness (What is dizziness?), headache (What is headache?), hypercholesterolaemia, musculoskeletal pain, myalgia, oophorectomy. Femara dosage: 01 Daily. During the same period patient was treated with ZOMETA (Every Six Months) (View Zometa Review and Zometa Label ), IBUPROFEN (600, If Required) (View Ibuprofen Review and Ibuprofen Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6690144-6 |
Patient was taking Femara (View Usage). on Apr 17, 2010 from MEXICO Additional patient health information: Female patient , 87 years of age, was diagnosed with neoplasm malignant and. Femara dosage: 2.5 Mg, Qd.

6690138-0 |
Adverse event was reported on Apr 18, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) . Location: MEXICO , 94 years of age, .

6687456-9 |
on Apr 15, 2010 Female patient from MEXICO , 55 years of age, was diagnosed with neoplasm malignant and was treated with Femara (View Usage). . Femara dosage: 2.5 Mg, Qd.

6687455-7 |
on Apr 15, 2010 Female patient from MEXICO , 26 years of age, was treated with Femara (View Usage). . Femara dosage: 2.5 Mg, Unk.

6687454-5 | Dyspnoea, Pneumonia, Renal Impairment, Respiratory Arrest
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: dyspnoea, pneumonia (What is pneumonia?), renal impairment, respiratory arrest on Apr 15, 2010 from BRAZIL Additional patient health information: Female patient , 67 years of age, was diagnosed with breast cancer (What is breast cancer?), hypertension, gastric disorder and. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with PROPRANOLOL (80mg (two Tablets) Daily) (View Propranolol Review and Propranolol Label ), NEXIUM (20 Mg (1 Tablet) Daily) (View Nexium Review and Nexium Label ), ALDACTONE (100 Mg (1 Tablet) Daily) (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6683099-1 | Surgery
Adverse event was reported on Apr 12, 2010 by a Female patient taking Femara (View Usage) (Dosage: 1 Tablet (2.5 Mg) Per Day) was diagnosed with hypertension and. Location: MEXICO , 73 years of age, Patient experienced the following unwanted or unexpected effects: surgery (What is surgery?). During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6683074-7 | Dyspepsia, Gastric Lavage, Influenza, Nausea, Nervous System Disorder, Sleep Disorder
on Apr 09, 2010 Female patient from MEXICO , 69 years of age, was treated with Femara (View Usage). Patient had the following side effects: dyspepsia, gastric lavage, influenza, nausea (What is nausea?), nervous system disorder, sleep disorder (What is sleep disorder?). Femara dosage: 2.5 Mg, Qd 1 Tablet Per Day. Patient was hospitalized.

6683067-X | Abdominal Pain, Adenoma Benign, Colon Neoplasm, Colon Polypectomy, Colonic Polyp, Staphylococcal Infection, Tumour Excision
on Apr 08, 2010 Female patient from UNITED STATES , weighting 189.6 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), adenoma benign, colon neoplasm, colon polypectomy, colonic polyp (What is colonic polyp?), staphylococcal infection (What is staphylococcal infection?), tumour excision. Femara dosage: 2.5 Mg, Qd. Patient was hospitalized.

6680853-7 | Bone Disorder, Cardiac Disorder, Dyspnoea, Fluid Retention, Insomnia, Musculoskeletal Stiffness, Oedema Peripheral, Pain In Extremity, Somnolence
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, cardiac disorder, dyspnoea, fluid retention, insomnia, musculoskeletal stiffness, oedema peripheral, pain in extremity, somnolence on Apr 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 255.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 2.5 Mg. Od Hs Po.

6675584-3 | Adenocarcinoma, Biopsy Bone, Bone Sarcoma, Fibrosis, Metastases To Bone
Adverse event was reported on Apr 01, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: BRAZIL , weighting 119.0 lb, Patient had the following side effects: adenocarcinoma, biopsy bone, bone sarcoma, fibrosis, metastases to bone. Patient was hospitalized.

6675583-1 | Arthropathy, Fall, Knee Operation, Osteopenia
on Mar 30, 2010 Female patient from UNITED STATES , weighting 193.0 lb, was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: arthropathy, fall (What is fall?), knee operation, osteopenia. Femara dosage: 2.5 Daily.

6673041-1 | Retinal Vein Occlusion
on Mar 31, 2010 Female patient from JAPAN , 59 years of age, was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vein occlusion. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with FLUVASTATIN (30 Mg) (View Fluvastatin Review and Fluvastatin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6673037-X | Hyperglycaemia
Patient was taking Femara (View Usage). Patient had the following side effects: hyperglycaemia on Mar 31, 2010 from BRAZIL Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 01 Tablet Daily.